Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Gaetano Gargiulo
Has grant
Group Leader
Research Interests
Explore related searches
Recent Grants
Grant: Close
Generation, validation and use of a synthetic reporter of CAR T cell products function and dysfunction
Open Date: 2024-03-01
Close Date: 2025-08-01
Grant: Close
Generation and validation of a panel of EMT reporter cell lines from solid tumors
Open Date: 2022-07-01
Close Date: 2023-12-01
Grant: Close
Glioblastoma Subtype Avatar models for Target Discovery and Biology
Open Date: 2017-07-01
Close Date: 2023-06-01
Grant: Close
Testing therapeutic response to Polycomb inhibition in preclinical mouse models of Kras mutant lung cancer
Open Date: 2015-10-01
Close Date: 2018-10-01
Grant: Close
Functional identification of novel genes implicated in Glioblastoma Multiforme
Open Date: 2013-01-01
Close Date: 2016-01-01
Articles (8)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Tumors represent ecosystems where subclones compete during tumor growth. While extensively investigated, a comprehensive picture of the interplay of clonal lineages during dissemination is still lacking. Using patient-derived pancreatic cancer cells, we created orthotopically implanted clonal replica tumors to trace clonal dynamics of unperturbed tumor expansion and dissemination. This model revealed the multifaceted nature of tumor growth, with rapid changes in clonal fitness leading to continuous reshuffling of tumor architecture and alternating clonal dominance as a distinct feature of cancer growth. Regarding dissemination, a large fraction of tumor lineages could be found at secondary sites each having distinctive organ growth patterns as well as numerous undescribed behaviors such as abortive colonization. Paired analysis of primary and secondary sites revealed fitness as major contributor to dissemination. From the analysis of pro- and nonmetastatic isogenic subclones, we identified a transcriptomic signature able to identify metastatic cells in human tumors and predict patients’ survival.
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (15)
Deniz Demircioglu
Assistant Professor
Icahn School of Medicine at Mount Sinai
Andrea Viale
The University of Texas MD Anderson Cancer Center
Davide Cora'
Associate Professor
Università degli Studi del Piemonte Orientale
Daniel Lozano-Ojalvo
Consejo Superior de Investigaciones Cientificas
Viktoria Haug
University Hospital Frankfurt
Sara Sigismund
Principal Investigator
European Institute of Oncology
Rutvi Shah
The University of Texas MD Anderson Cancer Center
Alberto Ballestín
Beatriz Galindo Professor (Research Talent Attraction, Ministry of Science-MICIU, Spain)
Universidad de Extremadura
Sara Gandini
Group Leader T, PhD
European Institute of Oncology
Dario Polli
Associate Professor
Politecnico di Milano
Tiziana Bonaldi
Contract Professor
Università degli Studi di Torino
Jérémy Raymond
University of Oxford
Lukas Chavez
Associate Professor
University of California, San Diego
Owen J. Sansom
Director
Cancer Research UK Beatson Institute
Linghua Wang
Associate Professor
The University of Texas MD Anderson Cancer Center
Make your next move.
Prepare your application
Review drafts before you send them.